Stuart Mclaughlin
Triple Frond Partners
Triple Frond Partners DaVita HealthCare Partners Inc stake
total: 42
Triple Frond Partners DVA trades
- Total transactions:
- 7
- New positions:
- 1
- Sold out:
- 1
- Added:
- 2
- Reduced:
- 3
- Held since:
- 2014 Q3
- Held for:
- 9 quarters
- Latest activity:
- 2016 Q4
According to 2026 Q1 report, Triple Frond Partners doesn't hold any DaVita HealthCare Partners Inc (DVA) shares. To date, the estimated cost basis is nearly $72.12 for "buy" trades and estimated average "sell" price is $68.68. Triple Frond Partners first purchased DVA in 2014 Q3, initially acquiring 550,000 shares. Since the initial investment in DaVita HealthCare Partners Inc (DVA), Triple Frond Partners has made 6 more transactions.
When did Triple Frond Partners sell DaVita HealthCare Partners Inc (DVA)?
Triple Frond Partners sold off the entire DaVita HealthCare Partners Inc (DVA) position in 2016 Q4.
When did Triple Frond Partners buy DaVita HealthCare Partners Inc (DVA)?
Triple Frond Partners first invested in DaVita HealthCare Partners Inc (DVA) in 2014 Q3 at the reported quarter-end price of $73.14 per share.
What's the cost basis of Triple Frond Partners's DVA stake?
The estimated cost basis for DaVita HealthCare Partners Inc (DVA) stake is around $72.12 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $72.12
- Weighted AVG sell price:
- $68.68
Triple Frond Partners's historical trades in DaVita HealthCare Partners Inc
7 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2016 Q4
|
0.00%
|
$66.07
|
-100% (-674,300)
|
|||
|
2016 Q3
|
6.35%
|
$66.07
|
-5.77% (-41,300)
|
|||
|
2016 Q2
|
8.90%
|
$77.32
|
-15.81% (-134,400)
|
|||
|
2016 Q1
|
10.16%
|
$73.38
|
-15.00% (-150,000)
|
|||
|
2015 Q4
|
13.00%
|
$69.71
|
+33.33% (+250,000)
|
|||
|
2015 Q3
|
11.48%
|
$72.33
|
+36.36% (+200,000)
|
|||
|
2014 Q3
|
18.65%
|
$73.14
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.